Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis.

This study documented clear evidence for immune activation in chronic fatigue syndrome, including increases in interleukin-10, interferon-gamma, TNF-alpha and  CD4+CD25+ T cells ( a result of viruses and other pathogens implicated in this disorder ?)


Chronic fatigue risk factors:
Enhanced by Zemanta

No comments: